new Glioblastoma treatment attacks brain tumors from multiple angles
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
On Nov. 6, 2024, a trio of new studies with funding from Cancer Grand Challenges revealed the unfair advantage…
On Nov. 5, 2024, a cross-sectional study of data for 36 cancer types from 185 countries and territories…
On Oct. 29, 2024, a study led by Andrei Gudkov, PhD, DSci, at Roswell Park Comprehensive Cancer Center support…
On Oct. 29, 2024, a study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center (UCLA…
On Oct. 4, 2024, the World Health Organization (WHO) announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine…
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Oct. 2, 2024, a study from the GBD Tobacco Forecasting Collaborators reported that by accelerating the decline…
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Sep. 4, 2024, an international consortium led by scientists from Uppsala University in Sweden reported that the…
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
On Aug. 29, 2024, researchers at the Garvan Institute of Medical Research announced they had mapped 50,000 of…
On Aug. 23, 2024, A team of researchers from the University of Cologne announced they had created a…
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
On Jul. 17, 2024, the National Cancer Institute (NCI) announced that a study, funded in part by the…
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Asian American and Pacific Islander History Month celebrates the scientific accomplishments of several firsts, from the first chemo…
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenï¾’s Health Research, an effort led…
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
On Oct. 26, 2022, the National Institutes of Health announced that overall cancer death rates continued to decline…
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…